Ranbaxy Hit With Class Action Over Generic Lipitor Recall

Law360, New York (December 4, 2012, 3:21 PM EST) -- Ranbaxy Inc. was hit with a putative class action filed in New Jersey federal court last week, alleging the company’s recall of its generic version of blockbuster cholesterol treatment Lipitor did not warn or compensate consumers adequately of the drug.

Ranbaxy, the American arm of India-based drugmaker Ranbaxy Laboratories Ltd., began recalling 41 lots of generic Lipitor, or atorvastatin, from retailers Nov. 9, because of concerns the pills might contain tiny glass fragments, comparable to fine grains of sand less than one millimeter in size, according...
To view the full article, register now.